Company News
SED Pharma Concludes CIPM 2026 in Xiamen

SED Pharma has concluded its participation in the 68th China National Pharmaceutical Machinery Exposition and 2026 China International Pharmaceutical Machinery Exposition (CIPM 2026), held at Xiamen International Expo Center from October 27 to 29, 2026. At booth 9-B62, the SED Pharma team met visitors from the pharmaceutical industry and presented equipment for pharmaceutical processing and packaging applications.
The three-day event brought together suppliers, manufacturers and technical professionals around pharmaceutical production. For SED Pharma, the exhibition provided a practical setting to discuss project requirements face to face, including dosage form, packaging format, production workflow and the equipment configuration that may be relevant to a specific application.
A focused presence at booth 9-B62
SED Pharma presented equipment alongside its pharmaceutical machinery and packaging capabilities. The team met visitors at booth 9-B62 to review equipment requirements and discuss potential applications. These conversations were application-led rather than based on a one-size-fits-all equipment recommendation: a suitable configuration depends on the product, expected output, container or package format, facility conditions and applicable quality requirements.
The exhibition also gave visitors an opportunity to see equipment in person, ask operational questions and exchange initial project information with the team. Where a project moves forward, the next step is to define the actual process, materials, target capacity and integration requirements in sufficient detail for an engineering discussion.
Conversations around pharmaceutical equipment needs
During the exhibition, the team discussed the broad range of requirements that can shape an equipment project. Pharmaceutical manufacturers may need to assess a single machine, an expansion to an existing line, or a more connected processing and packaging workflow. In each case, the useful starting point is not a generic performance claim but a clear picture of the product and the operating conditions.
For oral solid dosage products, for example, those details may include product form, batch size, dosing approach, container or blister format, available utilities, cleaning expectations and downstream handling. Similar questions apply to other pharmaceutical and health-product applications. Defining them early helps narrow the discussion to equipment categories and options that are relevant to the intended use.
From exhibition discussion to project review
CIPM 2026 has now closed, but the project discussions begun in Xiamen can continue after the event. SED Pharma can review production requirements with prospective customers and clarify the information needed to evaluate an equipment proposal. This may include product samples or drawings where appropriate, process sequence, target output, layout constraints and the standards or documentation expected for the project.
The goal is to turn an initial exhibition conversation into a practical next step: a defined equipment scope, a clearer understanding of interface requirements, or a technical inquiry that can be assessed against the actual manufacturing task. Final equipment suitability remains project-specific and should be confirmed against the agreed specification and applicable requirements.
Thank you to visitors and partners
SED Pharma thanks the visitors, customers and industry partners who met the team during CIPM 2026. The company appreciates the opportunity to exchange views on pharmaceutical processing and packaging projects and looks forward to following up on the requirements discussed in Xiamen.
To continue a conversation started at the exhibition, or to begin a new equipment inquiry, contact SED Pharma with the product type, intended process, target capacity and main project constraints. The team can then direct the discussion to the appropriate pharmaceutical machinery options.